Powder River Coal Aktie
ISIN: US73886P1003
|
20.11.2025 15:48:38
|
Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer
On November 14, 2025, Bain Capital Life Sciences Investors, LLC disclosed a purchase of 520,310 shares of Cidara Therapeutics (NASDAQ:CDTX), increasing its position value by approximately $167.48 million.Bain Capital Life Sciences Investors, LLC reported in a November 14, 2025, SEC filing that it increased its stake in Cidara Therapeutics by 520,310 shares during the third quarter. The position’s value rose to $289.29 million, up from the previous period. The transaction contributed an estimated $167.48 million in value change, factoring in both share purchases and price appreciation.This buy brought the CDTX stake to 19.2% of the fund’s 13F reportable assets under management, making it the 3rd-largest holding.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!